Catalog No.
RHC05301
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Alpaca
Isotype
VHH-8His-Cys-tag
Clonality
Monoclonal
Target
Catalase, CAT
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Purified by Nickel column.
Accession
P04040
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA1202
Deep-Red and Ultrafast Photocatalytic Proximity Labeling Empowered In Situ Dissection of Tumor-Immune Interactions in Primary Tissues., PMID:40036744
Antibody fragments targeting the extracellular domain of follicular stimulating hormone receptor for contraception in male dogs and cats., PMID:38875921
Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species., PMID:38352869
Modulation of cell physiology by bispecific nanobodies enabling changes in the intracellular localization of organelle proteins., PMID:37506923
Caplacizumab in acquired thrombotic thrombocytopenic purpura: Dose adjustment based on von Willebrand factor level., PMID:37385936
Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2., PMID:37095076
Neutralizing epitopes on Clostridioides difficile toxin A revealed by the structures of two camelid VHH antibodies., PMID:36466927
Probing the structure and function of the protease domain of botulinum neurotoxins using single-domain antibodies., PMID:34990480
Moderating hypoxia and promoting immunogenic photodynamic therapy by HER-2 nanobody conjugate nanoparticles for ovarian cancer treatment., PMID:34319255
Targeted nanobody complex enhanced photodynamic therapy for lung cancer by overcoming tumor microenvironment., PMID:33292202
Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI)., PMID:33221124
Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells., PMID:32992561
Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins., PMID:32101733
Single-domain antibodies pinpoint potential targets within Shigella invasion plasmid antigen D of the needle tip complex for inhibition of type III secretion., PMID:28842484
A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding., PMID:28785006
For research use only. Not for human or drug use.
